Dr. Santoro provides insight on the recent ruling on using vaginal estrogen for breast cancer symptoms
The American College of Obstetricians and Gynecologists (ACOG) recently endorsed the use of vaginal estrogen for breast cancer survivors to treat urogenital symptoms. Vaginal estrogen currently contains a black box warning, which tends to deter cancer survivors from using it. Dr. Nanette Santoro discussed this in an online panel published on MedPage Today.
“It’s not appropriate for a physician to turn his or her back on a patient’s suffering and tell her there’s nothing that can be done. Virtually every medication interaction involves a risk-to-benefit calculation,” Santoro said in the article. “That’s what doctors are trained to provide.”